High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hu, Zhenhua ^a   Gao, Jian ^a   Zhang, Danye ^a   Liu, Qing ^a   Yan, Limei ^a   Gao, Lili ^a   Liu, Juanjuan ^a   Liu, Dawo ^a   Zhang, Shulan ^a   Lin, Bei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; HERMES ANTIGEN; LEWIS Y ANTIGEN; PACLITAXEL; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; OVERALL SURVIVAL; RISK FACTOR; TUMOR VOLUME; UPREGULATION;

ANTIGENS, CD44; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEWIS BLOOD-GROUP SYSTEM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS;

EID: 84874514405     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057250     Document Type: Article

References (29)

1. Xie Z, Choong PF, Poon LF, Zhou J, Khng J, et al. (2008) Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion. Cancer Chemother Pharmacol 6: 949-57.
2. Ohashi R, Takahashi F, Cui R, Yoshioka M, Gu T, et al. (2007) Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. Cancer Lett 252: 225-34.
3. Makrydimas G, Zagorianakou N, Zagorianakou P, Agnantis NJ, (2003) CD44 family and gynaecological cancer. In Vivo 17: 633-640.
4. Slominay MG, Dai L, Tolliver LB, Grass GD, Zeng Y, et al. (2009) Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides. Clin Cancer Res 15: 7593-7601.
5. English NM, Lesley JF, Hyman R, (1998) Site-apecific de-N-glycosylation of CD44 can activate Hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res 16: 3736-42.
6. Gao L, Yan L, Lin B, Gao J, Liang X, et al. (2011) Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-1. J Exp Clin Cancer Res 30: 15.
7. Iwamori M, Tanoka K, Lin B, Kiguchi K, Ishiwata I, et al. (2005) Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the alpha 1,2-fucosyltransferase gene. Cancer Sci 96: 26-30.
8. Zhao Y, Lin B, Hao YY, Yan LM, Liu JJ, et al. (2008) The effects of Lewis(y) antigen content on drug resistance to carboplatin in ovarian cancer line RMG-1. Prog Biochem Biophys 35: 1175-82.
9. Oliver L, Corder S, Barbieux I, LeCabellec MT, Meflah K, et al. (2002) resistance to apoptosis is invreased during metastatic dissemination of colon cancer. Clin Exp Metastasis 19: 175-80.
10. Hetweck MK, Erdfelder F, Kreuzer KA, (2011) CD44 in hematological neoplasias. Ann Hematol 5: 493-508.
11. Abelson S, Shamai Y, Berger L, Shouval R, Skorechi K, et al. (2012) Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer. Stem Cells 30: 415-424.
12. Shi MF, Jiao J, Lu WG, Ye F, Ma D, et al. (2010) Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line. Cell Mol Life Sci 67: 3915-3925.
13. Beretta GL, Benedetti V, Cossa G, Assaraf YG, Bram E, et al. (2010) Increased levels and defective N-glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin. Biochem Pharmacol 79: 1108-1117.
14. Yap YH, Say YH, (2011) Resistance against apoptosis by the cellular prion protein is dependent on its glycosylation status in oral HSC-2 and colon LS174T cancer cells. Cancer Lett 306: 111-119.
15. Kudo T, Nakagawa H, Takahashi M, Hamaquchi J, Kamiyama N, et al. (2007) N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma. Mol Cancer 9,6: 32.
16. Lakshman Minalini, Venkateswaran S, (2005) CD44 promotes resistance to apoptosis in murine colonic epithelium. Journal of Cellular Physiology 203: 583-588.
17. Lakshman Minalini, Subramaniam Venkateswaran, (2004) CD44 promotes resistance to apoptosis in human colon cancer cells. Experimental and Molecular Pathology 77: 18-25.
18. Bourgiugnon LY, Singleton PA, Zhu H, Diedrich F, (2003) Hyaluronan-mediated CD44 interaction with Rho GEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem 278: 29420-29434.
19. Steven J, Wang MD, Peyrollier Karine, (2007) The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Arch Otolaryngol Head Neck Surg 133: 281-288.
20. Bourguignon LY, Pevrollier K, Xia W, Gilad E, (2008) Hyaluronan-CD44 interaction activates stem cell marker nanog, stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Bio Chem 283: 17635-17651.
21. Wang SJ, Bourguignon LY, (2006) Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy. Arch Otolaryngol Head Neck Surg 132: 771-778.
22. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, et al. (2008) the multidrug transporter P-glycoprotein: a mediator of melanoma invasion. J Invest Dermatol 128: 957-971.
23. Liu J, Lin B, Hao Y, Qi Y, Zhu L, et al. (2009) Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-1 cells through the PI3K/Akt signaling pathway. J Exp Clin Cancer Res 28: 154.
24. Santiskulvong C, Konecny GE, Fekete M, Chen KY, Karam A, et al. (2011) Dual targeting of phosphoinositide-3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma. Clin Cancer Res 17: 2373-2384.
25. Wang C, Yan L, Wang Y, Lin B, Liu S, et al. (2011) Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplation of Topo-I and Topo-IIβ. Anat Rec 294: 961-969.
26. Cong JP, Lin B, Liu JJ, Liu Q, Li FF, (2010) The effect of α1,2-fucosyltransferase gene tansfection on P38 MAPK signaling pathway-mediated apoptosis of ovarian carcinoma RMG-1 cells. Progress in Biochemistry and Biophysics 37: 175-183.
27. Yan LM, Lin B, Zhu LC, Hao YY, Qi Y, et al. (2010) Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin α5β1 with the Lewis Y-structure on tansfection of the α1,2-fucosyltransferase gene. Biochimie 92: 852-857.
28. Wang Y, Liu J, Lin B, Wang C, Li Q, et al. (2011) Study on the expression and clinical significances of Lewis y antigen and integrin αv,β3 in epithelial ovarian tumors. Int J Mol Sci 12: 3409-3421.
29. Liu JJ, Lin B, Hao YY, Li FF, Liu DW, et al. (2010) Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. Oncol Rep 23: 833-841.